H E Broxmeyer

4.8k total citations · 2 hit papers
47 papers, 3.9k citations indexed

About

H E Broxmeyer is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, H E Broxmeyer has authored 47 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 19 papers in Immunology and 17 papers in Molecular Biology. Recurrent topics in H E Broxmeyer's work include Hematopoietic Stem Cell Transplantation (10 papers), Mesenchymal stem cell research (6 papers) and Chemokine receptors and signaling (6 papers). H E Broxmeyer is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Mesenchymal stem cell research (6 papers) and Chemokine receptors and signaling (6 papers). H E Broxmeyer collaborates with scholars based in United States, France and Netherlands. H E Broxmeyer's co-authors include Anne Thomas, Judith Bard, M. Arny, English D, Edward A. Boyse, Sandra K. Cooper, Malcolm A.S. Moore, Saroj Vadhan‐Raj, A LeMaistre and José M. Trujillo and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

H E Broxmeyer

46 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.

1989 844 citations H E Broxmeyer, Sandra K. Cooper et al. Proceedings of the National Academy of Sciences profile →
Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic Syndromes

1987 509 citations Saroj Vadhan‐Raj, Michael J. Keating et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H E Broxmeyer United States	26	2.0k	1.5k	974	940	897	47	3.9k
HE Broxmeyer United States	32	2.7k 1.4×	1.5k 1.0×	935 1.0×	1.2k 1.3×	1.4k 1.5×	68	4.7k
JD Griffin United States	25	2.1k 1.1×	1.9k 1.3×	1.2k 1.2×	1.3k 1.4×	545 0.6×	61	4.7k
JH Falkenburg Netherlands	33	1.5k 0.7×	1.8k 1.2×	837 0.9×	621 0.7×	644 0.7×	88	3.3k
Eileen Bryant United States	42	3.6k 1.8×	888 0.6×	872 0.9×	1.3k 1.4×	1.0k 1.1×	82	5.3k
TM Dexter United Kingdom	27	1.6k 0.8×	970 0.6×	1.3k 1.4×	620 0.7×	588 0.7×	58	3.2k
Fawzia Louache France	37	1.6k 0.8×	1.3k 0.8×	827 0.8×	1.0k 1.1×	633 0.7×	92	3.8k
Nydia G. Testa United Kingdom	30	1.4k 0.7×	678 0.4×	808 0.8×	830 0.9×	681 0.8×	105	3.0k
KM Zsebo United States	40	2.3k 1.1×	2.6k 1.7×	972 1.0×	1.7k 1.8×	952 1.1×	82	5.6k
A. Lindemann Germany	32	892 0.4×	1.8k 1.2×	1.1k 1.2×	749 0.8×	366 0.4×	87	3.3k
W Hinterberger Austria	30	1.8k 0.9×	978 0.6×	646 0.7×	314 0.3×	519 0.6×	124	3.0k

Countries citing papers authored by H E Broxmeyer

Since Specialization

Citations

This map shows the geographic impact of H E Broxmeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H E Broxmeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H E Broxmeyer more than expected).

Fields of papers citing papers by H E Broxmeyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H E Broxmeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H E Broxmeyer. The network helps show where H E Broxmeyer may publish in the future.

Co-authorship network of co-authors of H E Broxmeyer

This figure shows the co-authorship network connecting the top 25 collaborators of H E Broxmeyer. A scholar is included among the top collaborators of H E Broxmeyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H E Broxmeyer. H E Broxmeyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Broxmeyer, H E. (2005). Biology of cord blood cells and future prospects for enhanced clinical benefit. Cytotherapy. 7(3). 209–218. 56 indexed citations

Youn, Byung‐S., Charlie Mantel, & H E Broxmeyer. (2000). Chemokines, chemokine receptors and hematopoiesis. Immunological Reviews. 177(1). 150–174. 112 indexed citations

Broxmeyer, H E, et al.. (1996). Involvement of Interleukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homologue.. The Journal of Experimental Medicine. 184(5). 1825–1832. 98 indexed citations

Broxmeyer, H E, Stephanie Cooper, Nancy Hague, et al.. (1995). Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice. Annals of Hematology. 71(5). 235–246. 9 indexed citations

Mantel, Charlie, Susan M. Aronica, Zhuojing Luo, et al.. (1995). Macrophage inflammatory protein-1 alpha enhances growth factor-stimulated phosphatidylcholine metabolism and increases cAMP levels in the human growth factor-dependent cell line M07e, events associated with growth suppression.. The Journal of Immunology. 154(5). 2342–2350. 18 indexed citations

Broxmeyer, H E. (1995). Questions to be answered regarding umbilical cord blood hematopoietic stem and progenitor cells and their use in‐transplantation. Transfusion. 35(8). 694–702. 40 indexed citations

Broxmeyer, H E, Scott Cooper, Nancy Hague, et al.. (1995). Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice. Annals of Hematology. 71(5). 235–246. 58 indexed citations

Tauchi, Tetsuzo, H. Scott Boswell, D Leibowitz, & H E Broxmeyer. (1994). Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.. The Journal of Experimental Medicine. 179(1). 167–175. 115 indexed citations

Kreisberg, Robert A., H E Broxmeyer, & Robert N. Moore. (1994). Ferritin stimulation of a monokine inhibitor of lipopolysaccharide-augmented myelopoiesis is ferroxidase dependent. Infection and Immunity. 62(7). 2991–2994. 1 indexed citations

10.

Mantel, Charlie, et al.. (1993). Steel Factor and Granulocyte-Macrophage Colony-Stimulating Factor Act Together to Enhance Choline-Lipid Turnover during Synergistically Stimulated Proliferation of the Human Factor-Dependent Cell Line, M07e. Biochemical and Biophysical Research Communications. 197(2). 978–984. 7 indexed citations

11.

Broxmeyer, H E, Scott Cooper, Mervin C. Yöder, & Giao Hangoc. (1992). Human Umbilical Cord Blood as a Source of Transplantable Hematopoietic Stem and Progenitor Cells. Current topics in microbiology and immunology. 177. 195–204. 17 indexed citations

12.

Hendrie, Paul C., Keisuke Miyazawa, Young Chul Yang, Carl D. Langefeld, & H E Broxmeyer. (1991). Mast cell growth factor (c-kit ligand) enhances cytokine stimulation of proliferation of the human factor-dependent cell line, M07e.. PubMed. 19(10). 1031–7. 93 indexed citations

13.

Broxmeyer, H E, Sandra K. Cooper, Judith Bard, et al.. (1989). Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.. Proceedings of the National Academy of Sciences. 86(10). 3828–3832. 844 indexed citations breakdown →

14.

Zucali, James R., H E Broxmeyer, M.A. Gross, & C A Dinarello. (1988). Recombinant human tumor necrosis factors alpha and beta stimulate fibroblasts to produce hemopoietic growth factors in vitro.. The Journal of Immunology. 140(3). 840–844. 56 indexed citations

15.

Williams, DE, et al.. (1988). Purified murine granulocyte/macrophage progenitor cells express a high-affinity receptor for recombinant murine granulocyte/macrophage colony-stimulating factor.. Proceedings of the National Academy of Sciences. 85(2). 487–491. 18 indexed citations

16.

Vadhan‐Raj, Saroj, Michael J. Keating, A LeMaistre, et al.. (1987). Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic Syndromes. New England Journal of Medicine. 317(25). 1545–1552. 509 indexed citations breakdown →

17.

Broxmeyer, H E, Wanda Piacibello, L Juliano, et al.. (1986). Gamma interferon induces colony-forming cells of the human monoblast cell line U937 to respond to inhibition by lactoferrin, transferrin, and acidic isoferritins.. PubMed. 14(1). 35–43. 12 indexed citations

18.

Broxmeyer, H E, L Juliano, Lu Li, E Platzer, & Bo Dupont. (1984). HLA-DR human histocompatibility leukocyte antigens-restricted lymphocyte-monocyte interactions in the release from monocytes of acidic isoferritins that suppress hematopoietic progenitor cells.. Journal of Clinical Investigation. 73(4). 939–953. 21 indexed citations

19.

Broxmeyer, H E, Ling Lu, E Platzer, et al.. (1983). Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.. The Journal of Immunology. 131(3). 1300–1305. 302 indexed citations

20.

Broxmeyer, H E, et al.. (1978). In Vitro Suppression of Normal Granulocytic Stem Cells by Inhibitory Activity DerivedFrom Human Leukemia Cells 23. JNCI Journal of the National Cancer Institute. 60(3). 497–511. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact